Recent News Stories

Thu, Apr 16, 2015 - 10:18
On April 3, 2015, NVHR submitted testimony to the Senate Labor-HHS Appropriations Subcommittee urging an increase in funding for viral hepatitis and an end to the ban on federal funding for syringe exchange programs.
Thu, Apr 02, 2015 - 10:30
The Center for Health Law and Policy Innovation of Harvard Law School has released a new report analyzing hepatitis C treatment access restrictions in Medicaid fee-for-service and managed care programs in 10 states.
Tue, Feb 10, 2015 - 11:57
President Obama proposes to double funding for CDC's Division of Viral Hepatitis.
Mon, Nov 03, 2014 - 07:35
The results of the National Viral Hepatitis Roundtable Steering Committee election have been announced.
 
 
 
 

Recent Posts

Mon, Mar 02, 2015 - 13:14
This webinar will cover the most important elements that patients need to know regarding screening, access to care, receiving and paying for treatment, and living with hepatitis C.
Mon, Jan 05, 2015 - 14:23
Tue, Aug 19, 2014 - 09:08
NVHR has created a fact sheet about The Viral Hepatitis Testing Act of 2014 (S. 2538). The legislation would authorize $80 million over three years for a comprehensive national system – an enhancement and strengthening of existing public health programs – for surveillance, education, testing, and linkage to care for HBV and HCV, to prevent transmission, morbidity, and mortality from viral hepatitis-related chronic liver disease and liver cancer.
Tue, Aug 19, 2014 - 09:07
NVHR has developed a fact sheet about The Viral Hepatitis Testing Act of 2013 (H.R. 3723). The legislation would authorize $80 million over three years for a comprehensive national system – an enhancement and strengthening of existing public health programs – for surveillance, education, testing, and linkage to care for HBV and HCV, to prevent transmission, morbidity, and mortality from viral hepatitis-related chronic liver disease and liver cancer.
Tue, Jul 29, 2014 - 14:58
People with chronic hepatitis C who are using methadone or buprenorphine to manage opiate addiction can be safely and effectively treated with AbbVie's 3D all-oral direct-acting antiviral regimen plus ribavirin, resulting in a 97% cure rate, according to a report this week at the 20th International AIDS Conference in Melbourne.